Hannah Norman - KFF Health News

The VA has long given veterans who served in Vietnam disability compensation for illness connected to Agent Orange. But those exposed at U.S. bases are still waiting for the same benefits.

With artificial intelligence in health care on the rise, eye screenings for diabetic retinopathy are emerging as one of the first proven use cases of AI-based diagnostics in a clinical setting.

At least 17 states have issued PFAS-related fish consumption advisories, KFF Health News found. But with no federal guidance, what is considered safe to eat varies significantly among states, most of which provide no regulation.

Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.

The full health risks of wearing apparel made with PFAS, also known as “forever chemicals,” are still unknown. But states are taking action so clothing makers will remove them.

Entrepreneurs see smartphones as an opportunity to meet patients where they are. But many app-based diagnostic tools still need clinical validation to get buy-in from health care providers.

Two rapid-testing initiatives the Biden administration released in the past week are inaccessible to some residents of multifamily housing, people who don’t speak English well, or those without internet access.

You probably won't be testing everyone at your Thanksgiving table for COVID because the tests are expensive and hard to find. The federal government is partly to blame.

Germans pay less than $1 per test. Brits get them free. Why do Americans pay so much more? Because companies can still demand it.

Because there are no caps on cost, consumers and insurers often get billed hundreds of dollars for the most reliable PCR test. Prices are rising and they can’t fight back.